Published August 13, 2024
| Version v1
Patent
Open
Methods and compositions related to triple-negative breast cancer
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
Embodiments are directed to kits and methods of treating a breast cancer patient with a glucocorticoid receptor antagonist with or without an anticancer agent or compound after the patient has been determined to be susceptible to treatment with the glucocorticoid receptor antagonist.
Files
US_12062444_B2.pdf
Files
(3.6 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:40010ec26c5abc1c8ac48451ff2bbaa3
|
3.6 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- 201816217350
- Patent number
- US 12062444 B2
- Other
- oai:uchicago.tind.io:14141
Dates
- Patent filed
-
2018-12-12